Joely Kaufman-Janette, MD
Dermatology · Coral Gables, FLNPI 1780648162
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (57.2%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 29 manufacturers reported payments, led by AbbVie at 48.1% of the total. Among dermatology clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 455 payments — averaging $530.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$116K
- Galderma Laboratories, L.p.$97K
- Endo Pharmaceuticals Inc.$11K
- Revance Therapeutics, Inc.$9K
- Osmotica Pharmaceutical Corp.$3K
- Solta Medical, A Division Of Bausch Health US, LLC$2K
- plus $3K from 23 others
Across 320 payments — averaging $12,909 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$3.6M
- Endo Pharmaceuticals Inc.$400K
- Galderma Laboratories, L.p.$86K
What the payments were for
- Consulting fees$138,28757%
- Speaking & faculty fees$85,24035%
- Travel & lodging$5,0602%
- Food & beverage$12,7995%
- Education$1650%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 200 | $116,087 |
| Galderma Laboratories, L.p. | 131 | $96,836 |
| Endo Pharmaceuticals Inc. | 15 | $11,123 |
| Revance Therapeutics, Inc. | 36 | $8,966 |
| Osmotica Pharmaceutical Corp. | 1 | $3,375 |
| Solta Medical, A Division Of Bausch Health US, LLC | 1 | $2,175 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 5 | $1,660 |
| Regeneron Healthcare Solutions, Inc. | 10 | $212 |
| E.r. Squibb & Sons, L.L.C. | 6 | $160 |
| Almirall LLC | 7 | $144 |
| Arcutis Biotherapeutics, Inc. | 6 | $120 |
| Incyte Corporation | 6 | $98 |
| Sun Pharmaceutical Industries Inc. | 5 | $95 |
| Aclaris Therapeutics, Inc. | 4 | $82 |
| Pfizer | 3 | $57 |
| Dermira, Inc. | 3 | $54 |
| Boehringer Ingelheim | 2 | $48 |
| Biofrontera Inc. | 2 | $39 |
| Amgen | 1 | $32 |
| Merz North America, Inc. | 2 | $31 |
| Sanofi | 1 | $24 |
| VYNE Pharmaceuticals Inc. | 1 | $22 |
| Covidien LP | 1 | $22 |
| Promius Pharma LLC | 1 | $20 |
| Lilly USA, LLC | 1 | $19 |
| Johnson & Johnson | 1 | $18 |
| EPI Health, LLC | 1 | $16 |
| Journey Medical Corporation | 1 | $13 |
| Mayne Pharma Commercial LLC | 1 | $6 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$241,552 in reported general payments places this provider in the 95th percentile of 1,147 dermatology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluorouracil | 25 | $1,275 |
| Triamcinolone Acetonide | 40 | $338 |
| Mupirocin | 20 | $148 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Coral Gables
- Jeremy GreenCoral Gables$952K
- Javier Alonso-LlamazaresCoral Gables$854K
- Francisco KerdelMiami$2.1M
- Brad GlickMargate$2M
- Robert KirsnerMiami$1.4M
- John MinniStuart$1.4M
- Gil YosipovitchMiami$1M
- Shino Bay AguileraFt Lauderdale$1M
- Robert SnyderPembroke Pines$1M
- Marc IngleseTallahassee$989K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.